Bevatas 400 mg Injection Supplier USA | Pharmaceutical Exporter from India

Bevatas 400 mg Injection: Advanced Anti-Angiogenic Therapy for Multi-Cancer Care

Are you searching for a reliable Bevatas 400 mg Injection exporter from India? Ernest Oncology, a dedicated vertical of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of high-quality oncology biologics. We provide a regulatory-compliant, cold-chain-integrated supply chain serving the USA, UK, Australia, and South Africa, ensuring that critical anti-cancer treatments reach healthcare institutions with pharmaceutical-grade integrity and efficient global logistics.

Detailed Product Overview: What is Bevatas 400 mg?

Bevatas 400 mg Injection is a recombinant humanized monoclonal antibody containing the active ingredient Bevacizumab. Manufactured by Intas Pharmaceuticals Ltd., Bevatas is a high-quality biosimilar to the reference product Avastin. It is specifically engineered to target and neutralize the vascular endothelial growth factor (VEGF), a key protein that tumors use to build their own blood supply.

For international B2B procurement, Bevatas 400 mg offers a clinically equivalent, cost-effective solution for treating various advanced malignancies. It is supplied as a 400 mg/16 ml solution in a single-dose vial for intravenous infusion.

Primary Therapeutic Indications

Bevatas 400 mg is used globally as a first-line or maintenance therapy for:

1. Metastatic Colorectal Cancer (mCRC): In combination with fluoropyrimidine-based chemotherapy.

2. Non-Small Cell Lung Cancer (NSCLC): First-line treatment of unresectable, locally advanced, or metastatic non-squamous NSCLC.

3. Glioblastoma Multiforme: For adult patients with progressive disease following prior therapy.

4. Metastatic Renal Cell Carcinoma (mRCC): In combination with interferon-alpha.

5. Ovarian & Cervical Cancers: For advanced, recurrent, or metastatic stages of epithelial ovarian, fallopian tube, and cervical cancer.

Mechanism of Action: The Science of Angiogenesis Inhibition

Bevatas works through a sophisticated mechanism known as angiogenesis inhibition:

• VEGF Neutralization: Bevacizumab binds specifically to the VEGF protein, preventing it from attaching to its receptors on the surface of endothelial cells (the cells that line blood vessels).

• Cutting Off the Supply: By blocking this signal, Bevatas prevents the formation of new blood vessels that tumors need to grow beyond a few millimeters.

• Tumor Regression: Existing tumor blood vessels may also shrink or become less "leaky," which can lower the pressure inside the tumor and allow other chemotherapy drugs to reach the cancer cells more effectively.

Administration and Clinical Safety

• Intravenous Infusion: Bevatas must be administered as a slow intravenous infusion by trained oncology professionals. It is NOT for IV bolus or push.

• Dosing Schedule: Usually administered once every 2 or 3 weeks, often synchronized with chemotherapy cycles.

• Storage Requirements: Must be stored in a cold chain at 2°C to 8°C (36°F to 46°F). Do not freeze or shake the vial, and protect it from light.

• Key Safety Monitoring:

  • Hypertension: Blood pressure should be monitored regularly during treatment.

  • Proteinuria: Periodic urine testing for protein levels is recommended.

  • Wound Healing: Treatment should be suspended at least 28 days prior to and following major surgery.

  • Gastrointestinal Risks: Patients should be monitored for signs of GI perforation or fistulae.

Why Source Bevatas from Ernest Oncology?

• Authentic Indian Exporter: Direct access to genuine Intas Pharmaceuticals inventory, providing 100% product authenticity and competitive wholesale pricing.

• Advanced Cold-Chain Management: We utilize validated thermal packaging to ensure Bevacizumab remains within the required temperature range during transit to the USA, UK, Australia, and South Africa.

• Regulatory Compliance: We provide all essential B2B documentation, including GMP compliance, batch-specific COAs, and export permits.

• Supply Chain Resilience: We specialize in large-scale procurement for oncology centers, government healthcare tenders, and regional pharmaceutical distributors.